Cagrilintide combined with semaglutide (CagriSema) for treatment of type 2 diabetes In a recent small phase 2 trial (n=92), 3 groups of patients with type 2 diabetes were randomized to receive cagrilintide co-administered with semaglutide (the authors called this combination CagriSema), cagrilintide or semaglutide, both in doses escalated to 2.4 mg once weekly (table 1) [10]
doi: 10.1016/j.cyto.2012.04.004 174 Diaz EncarnacionMMWarnerGMChengJGrayCENathKAGrandeJP
Frequently asked questions Can you take CLA and L-carnitine together safely For most healthy adults taking both at commonly studied doses is likely tolerated without major short term problems
For people with type 2 diabetes, blood sugar control typically improves or at least maintains during the switch
It occurs in three biological contexts with different functional consequences: type 1 EMT is involved in embryonic development and growth [52], type 2 EMT is involved in wound healing, tissue regeneration, and fibrosis [52], and Type 3 EMT, also known as oncogenic EMT, contributes to cancer metastasis [52,53,54,55]